Are withdrawal trials in paediatric rheumatic disease helpful?
Lehman
Thomas J A
TJ
Division of Pediatric Rheumatology, Hospital for Special Surgery, New York, NY 10021, USA. goldscout@aol.com
D000069594:Abatacept; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D002648:Child; D004311:Double-Blind Method; D006207:Half-Life; D006801:Humans; D018796:Immunoconjugates / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic / Q000379:methods*
D018501:Antirheumatic Agents; D018796:Immunoconjugates; D000069594:Abatacept